<VariationArchive VariationID="4425" VariationName="NM_001195248.2(APTX):c.689dup (p.Glu232fs)" VariationType="Duplication" Accession="VCV000004425" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2013-04-04" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19464" VariationID="4425">
      <GeneList>
        <Gene Symbol="APTX" FullName="aprataxin" GeneID="54840" HGNC_ID="HGNC:15984" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="32972616" stop="33025120" display_start="32972616" display_stop="33025120" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="32972603" stop="33001638" display_start="32972603" display_stop="33001638" Strand="-" />
          </Location>
          <OMIM>606350</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001195248.2(APTX):c.689dup (p.Glu232fs)</Name>
      <CanonicalSPDI>NC_000009.12:32984711:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9p21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="32984711" stop="32984712" display_start="32984711" display_stop="32984712" variantLength="1" positionVCF="32984711" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="32984709" stop="32984710" display_start="32984709" display_stop="32984710" variantLength="1" positionVCF="32984709" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>E160fs</ProteinChange>
      <ProteinChange>E232fs</ProteinChange>
      <ProteinChange>E144fs</ProteinChange>
      <ProteinChange>E178fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.32984710dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.32984710dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.32984712dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.32984712dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012821.2" sequenceAccession="NG_012821" sequenceVersion="2" change="g.45420dup">
            <Expression>NG_012821.2:g.45420dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195248.2" sequenceAccession="NM_001195248" sequenceVersion="2" change="c.689dup" MANESelect="true">
            <Expression>NM_001195248.2:c.689dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182177.2" sequenceAccession="NP_001182177" sequenceVersion="2" change="p.Glu232fs">
            <Expression>NP_001182177.2:p.Glu232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195249.2" sequenceAccession="NM_001195249" sequenceVersion="2" change="c.689dup">
            <Expression>NM_001195249.2:c.689dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182178.1" sequenceAccession="NP_001182178" sequenceVersion="1" change="p.Glu232fs">
            <Expression>NP_001182178.1:p.Glu232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195250.2" sequenceAccession="NM_001195250" sequenceVersion="2" change="c.527dup">
            <Expression>NM_001195250.2:c.527dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182179.2" sequenceAccession="NP_001182179" sequenceVersion="2" change="p.Glu178fs">
            <Expression>NP_001182179.2:p.Glu178fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195251.2" sequenceAccession="NM_001195251" sequenceVersion="2" change="c.689dup">
            <Expression>NM_001195251.2:c.689dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182180.1" sequenceAccession="NP_001182180" sequenceVersion="1" change="p.Glu232fs">
            <Expression>NP_001182180.1:p.Glu232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195252.2" sequenceAccession="NM_001195252" sequenceVersion="2" change="c.473dup">
            <Expression>NM_001195252.2:c.473dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182181.2" sequenceAccession="NP_001182181" sequenceVersion="2" change="p.Glu160fs">
            <Expression>NP_001182181.2:p.Glu160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195254.2" sequenceAccession="NM_001195254" sequenceVersion="2" change="c.527dup">
            <Expression>NM_001195254.2:c.527dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182183.1" sequenceAccession="NP_001182183" sequenceVersion="1" change="p.Glu178fs">
            <Expression>NP_001182183.1:p.Glu178fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368995.1" sequenceAccession="NM_001368995" sequenceVersion="1" change="c.689dup">
            <Expression>NM_001368995.1:c.689dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355924.1" sequenceAccession="NP_001355924" sequenceVersion="1" change="p.Glu232fs">
            <Expression>NP_001355924.1:p.Glu232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368996.1" sequenceAccession="NM_001368996" sequenceVersion="1" change="c.689dup">
            <Expression>NM_001368996.1:c.689dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355925.1" sequenceAccession="NP_001355925" sequenceVersion="1" change="p.Glu232fs">
            <Expression>NP_001355925.1:p.Glu232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368997.1" sequenceAccession="NM_001368997" sequenceVersion="1" change="c.689dup">
            <Expression>NM_001368997.1:c.689dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355926.1" sequenceAccession="NP_001355926" sequenceVersion="1" change="p.Glu232fs">
            <Expression>NP_001355926.1:p.Glu232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368998.1" sequenceAccession="NM_001368998" sequenceVersion="1" change="c.689dup">
            <Expression>NM_001368998.1:c.689dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355927.1" sequenceAccession="NP_001355927" sequenceVersion="1" change="p.Glu232fs">
            <Expression>NP_001355927.1:p.Glu232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368999.1" sequenceAccession="NM_001368999" sequenceVersion="1" change="c.689dup">
            <Expression>NM_001368999.1:c.689dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355928.1" sequenceAccession="NP_001355928" sequenceVersion="1" change="p.Glu232fs">
            <Expression>NP_001355928.1:p.Glu232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369000.1" sequenceAccession="NM_001369000" sequenceVersion="1" change="c.527dup">
            <Expression>NM_001369000.1:c.527dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355929.1" sequenceAccession="NP_001355929" sequenceVersion="1" change="p.Glu178fs">
            <Expression>NP_001355929.1:p.Glu178fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369001.1" sequenceAccession="NM_001369001" sequenceVersion="1" change="c.527dup">
            <Expression>NM_001369001.1:c.527dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355930.1" sequenceAccession="NP_001355930" sequenceVersion="1" change="p.Glu178fs">
            <Expression>NP_001355930.1:p.Glu178fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369002.1" sequenceAccession="NM_001369002" sequenceVersion="1" change="c.425dup">
            <Expression>NM_001369002.1:c.425dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355931.1" sequenceAccession="NP_001355931" sequenceVersion="1" change="p.Glu144fs">
            <Expression>NP_001355931.1:p.Glu144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369003.1" sequenceAccession="NM_001369003" sequenceVersion="1" change="c.425dup">
            <Expression>NM_001369003.1:c.425dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355932.1" sequenceAccession="NP_001355932" sequenceVersion="1" change="p.Glu144fs">
            <Expression>NP_001355932.1:p.Glu144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369004.1" sequenceAccession="NM_001369004" sequenceVersion="1" change="c.425dup">
            <Expression>NM_001369004.1:c.425dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355933.1" sequenceAccession="NP_001355933" sequenceVersion="1" change="p.Glu144fs">
            <Expression>NP_001355933.1:p.Glu144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369005.1" sequenceAccession="NM_001369005" sequenceVersion="1" change="c.425dup">
            <Expression>NM_001369005.1:c.425dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355934.1" sequenceAccession="NP_001355934" sequenceVersion="1" change="p.Glu144fs">
            <Expression>NP_001355934.1:p.Glu144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369006.1" sequenceAccession="NM_001369006" sequenceVersion="1" change="c.425dup">
            <Expression>NM_001369006.1:c.425dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355935.1" sequenceAccession="NP_001355935" sequenceVersion="1" change="p.Glu144fs">
            <Expression>NP_001355935.1:p.Glu144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370669.1" sequenceAccession="NM_001370669" sequenceVersion="1" change="c.425dup">
            <Expression>NM_001370669.1:c.425dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357598.1" sequenceAccession="NP_001357598" sequenceVersion="1" change="p.Glu144fs">
            <Expression>NP_001357598.1:p.Glu144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370670.1" sequenceAccession="NM_001370670" sequenceVersion="1" change="c.425dup">
            <Expression>NM_001370670.1:c.425dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357599.1" sequenceAccession="NP_001357599" sequenceVersion="1" change="p.Glu144fs">
            <Expression>NP_001357599.1:p.Glu144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370673.1" sequenceAccession="NM_001370673" sequenceVersion="1" change="c.425dup">
            <Expression>NM_001370673.1:c.425dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357602.1" sequenceAccession="NP_001357602" sequenceVersion="1" change="p.Glu144fs">
            <Expression>NP_001357602.1:p.Glu144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_175069.3" sequenceAccession="NM_175069" sequenceVersion="3" change="c.689dup">
            <Expression>NM_175069.3:c.689dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_778239.2" sequenceAccession="NP_778239" sequenceVersion="2" change="p.Glu232fs">
            <Expression>NP_778239.2:p.Glu232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_175073.3" sequenceAccession="NM_175073" sequenceVersion="3" change="c.689dup">
            <Expression>NM_175073.3:c.689dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_778243.1" sequenceAccession="NP_778243" sequenceVersion="1" change="p.Glu232fs">
            <Expression>NP_778243.1:p.Glu232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_036577.2" sequenceAccession="NR_036577" sequenceVersion="2" change="n.640dup">
            <Expression>NR_036577.2:n.640dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_160921.1" sequenceAccession="NR_160921" sequenceVersion="1" change="n.659dup">
            <Expression>NR_160921.1:n.659dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_160922.1" sequenceAccession="NR_160922" sequenceVersion="1" change="n.890dup">
            <Expression>NR_160922.1:n.890dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_160923.1" sequenceAccession="NR_160923" sequenceVersion="1" change="n.694dup">
            <Expression>NR_160923.1:n.694dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_160924.1" sequenceAccession="NR_160924" sequenceVersion="1" change="n.699dup">
            <Expression>NR_160924.1:n.699dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_160925.1" sequenceAccession="NR_160925" sequenceVersion="1" change="n.895dup">
            <Expression>NR_160925.1:n.895dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_160926.1" sequenceAccession="NR_160926" sequenceVersion="1" change="n.685dup">
            <Expression>NR_160926.1:n.685dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_160930.1" sequenceAccession="NR_160930" sequenceVersion="1" change="n.635dup">
            <Expression>NR_160930.1:n.635dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_160931.1" sequenceAccession="NR_160931" sequenceVersion="1" change="n.874dup">
            <Expression>NR_160931.1:n.874dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_175073.2" sequenceAccession="NM_175073" sequenceVersion="2" change="c.689dupT">
            <Expression>NM_175073.2:c.689dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA253141" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606350.0001" DB="OMIM" />
        <XRef Type="rs" ID="587776593" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 11586299 to determine the location of this variant on the current reference sequence. The 167insT is mapped on mRNA FLJ20157 (GenBank AK000164.1), which corresponds to 689dupT on NM_175073.2.</Comment>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001195248.2(APTX):c.689dup (p.Glu232fs) AND Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia" Accession="RCV000004675" Version="2">
        <ClassifiedConditionList TraitSetID="1218">
          <ClassifiedCondition DB="MedGen" ID="C1859598">Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001195248.2(APTX):c.689dup (p.Glu232fs) AND Inborn genetic diseases" Accession="RCV002512760" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-03-22" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11586299</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11586300</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15276230</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15876520</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21486904</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1218" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="347" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia</ElementValue>
                <XRef ID="MONDO:0008842" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adult onset ataxia with oculomotor apraxia</ElementValue>
                <XRef ID="Adult+onset+ataxia+with+oculomotor+apraxia/7641" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-oculomotor apraxia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-telangiectasia-like syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Early-onset cerebellar ataxia with hypoalbuminemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-oculomotor apraxia type 1</ElementValue>
                <XRef ID="1168" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EAOH</ElementValue>
                <XRef Type="MIM" ID="208920" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AOA</ElementValue>
                <XRef Type="MIM" ID="208920" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AOA1</ElementValue>
                <XRef Type="MIM" ID="208920" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EOCA-HA</ElementValue>
                <XRef Type="MIM" ID="208920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Ataxia with oculomotor apraxia type 1 (AOA1) is characterized by childhood onset of slowly progressive cerebellar ataxia, followed by oculomotor apraxia and a severe primary motor peripheral axonal motor neuropathy. The first manifestation is progressive gait imbalance (mean age of onset: 4.3 years; range: 2-10 years), followed by dysarthria, then upper-limb dysmetria with mild intention tremor. Oculomotor apraxia, usually noticed a few years after the onset of ataxia, progresses to external ophthalmoplegia. All affected individuals have generalized areflexia followed by a peripheral neuropathy and quadriplegia with loss of ambulation about seven to ten years after onset. Hands and feet are short and atrophic. Chorea and upper-limb dystonia are common. Intellect remains normal in some individuals; in others, different degrees of cognitive impairment have been observed.</Attribute>
                <XRef ID="NBK1456" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9283" />
                <XRef ID="9283" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301629</ID>
                <ID Source="BookShelf">NBK1456</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/ENS, 2014">
                <ID Source="PubMed">24418350</ID>
              </Citation>
              <XRef ID="1168" DB="Orphanet" />
              <XRef ID="C1859598" DB="MedGen" />
              <XRef ID="MONDO:0008842" DB="MONDO" />
              <XRef Type="MIM" ID="208920" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24849" SubmissionDate="2012-11-06" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606350.0001_ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA" title="APTX, 1-BP INS, 167T_ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA" />
        <ClinVarAccession Accession="SCV000024849" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Date et al. (2001) found that affected individuals in 3 pedigrees with EAOH (208920) carried a homozygous insertion of a T after nucleotide 167 (167delT; nucleotide number starting at the first ATG codon of the short form), which results in a frameshift with a premature stop. Affected individuals in these 3 families were homozygous; in 3 other pedigrees affected members had this mutation in heterozygous state in combination with a different mutation. Among their patients, Moreira et al. (2001) found that the Japanese founding haplotypes were associated with the same mutation, which they called 689insT according to the gene's long transcript.</Attribute>
              <Citation>
                <ID Source="PubMed">11586299</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11586300</ID>
              </Citation>
              <XRef DB="OMIM" ID="208920" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APTX" />
          </GeneList>
          <Name>APTX, 1-BP INS, 167T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 167T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606350.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6253546" SubmissionDate="2024-04-19" DateLastUpdated="2024-05-01" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="a9601746|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003558356" DateUpdated="2024-05-01" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15276230</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15876520</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21486904</ID>
          </Citation>
          <Comment>The c.689dupT (p.E232Gfs*38) alteration, located in exon 7 (coding exon 5) of the APTX gene, consists of a duplication of T at position 689, causing a translational frameshift with a predicted alternate stop codon after 38 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from the Genome Aggregation Database (gnomAD), the APTX c.689dupT alteration was not observed, with coverage at this position. The c.689dupT alteration has been reported in multiple patients in either homozygous or compound heterozygous with a second alteration who present with early onset ataxia with oculomotor apraxia, peripheral neuropathy, and hypoalbuminemia. Genotype-phenotype correlations suggest homozygotes are at an increased risk for inability to walk, early ocular motor apraxia onset less than 15 years of age, and cognitive impairment. This alteration has also been reported as c.689insT and c.689_690insT (Hirano, 2004; Ito, 2005: Yokoseki, 2011). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APTX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_175073.2:c.689dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6253546" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24849" TraitType="Disease" MappingType="Name" MappingValue="ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA" MappingRef="Preferred">
        <MedGen CUI="C1859598" Name="Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

